Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a intravenous solution for intravenous use. It replaces deficient antibodies and is used in primary immunodeficiency disorders and certain immune‑mediated conditions in both children and adults.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Panzyga is an immunoglobulin therapy indicated for diseases that involve antibody deficiency or dysregulation. - Primary immunodeficiency diseases (PID): provides supplemental IgG to reduce infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): helps maintain immune modulation to lessen neurologic deterioration. - Multifocal motor neuropathy (MMN): supplies IgG to improve muscle strength and functional ability. - Primary immune thrombocytopenia (ITP) refractory to other treatments: raises platelet counts by modulating immune response.

Panzyga            …  …  …  … ... ...